Two Cases of Acquired Hemophilia A Successfully Treated with Oral Steroid or Danazol

Sun Young Park, Jin Seok Kim, Yuri Kim, In Hae Park, June‐Won Cheong, Seung‐Tae Lee, Jee Sook Hahn, Yoo Hong Min
In: The Korean Journal of Hematology · 2005 · vol. 40(1) , pp. 58 · doi:10.5045/kjh.2005.40.1.58 · W2149300292
article OA: hybrid CC0
📄 Open PDF View on OpenAlex View at publisher

Abstract

Acquired Hemophilia A is a rare and considerably life-threatening coagulopathy, which is caused by the development of autoantibodies against factor VIII (FVIII) in non-hemophilic adults. Acquired FVIII inhibitors can be associated with diverse conditions, such as malignant disorders, medications, autoimmune diseases, postpartum states and others. These autoantibodies inhibit normal coagulation, had results in bleeding complications, which can contribute to mortality in a high percentages of cases. Effective control of the disorder can be achieved by prompt diagnosis and appropriate managements. Generally, the managements of acquired hemophilia A are aimed at treating the acute bleeding and eliminating inhibitors by immunosuppression. Although a range of treatment options exists for patients with acquired hemophilia A, there is no consensus with regard to the optimal therapies for this disorder. Herein, two cases, an 82-year-old man and a 78-year-old man who were successfully treated by steroid or danazol, which is a relatively mild immunosuppressive agent, are reported. (

My notes (saved in your browser only)

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (1)

References (17)

Source provenance

openalex
last seen: 2026-05-14T06:32:42.417794+00:00
License: CC0 · commercial use OK